The national competent authorities shall assess periodic safety update reports to determine whether there are new risks or whether risks have changed or whether there are changes to the risk-benefit balance of medicinal products.
Art. 107d Directive (EU) 2001/83
In forcesince 20 Jan 2011cited 1×
Judgment of the Court (Third Chamber) of 25 November 2021. Delfarma Sp. z o.o. v Prezes Urzędu Rejestracji Produktów Leczniczych, Wyrobów MeDecision
Articles 107i, 107j and 107k of that directive establish an urgent procedure within the European Union. That procedure must be initiated when a Member State or the European Commission plans to adopt measures relating to a marketing …
25 Nov 2021 · 62020CJ0488